Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence company, has established a wholly owned operating subsidiary in Venezuela as part of its strategy to expand healthcare technology initiatives in Latin America. The move is intended to facilitate market evaluation, strategic partnerships, and deployment of its AI-enabled platforms, including telehealth services, remote patient monitoring, and healthcare analytics.
According to the company's press release, the establishment of a local presence is a key step in its regional strategy, providing a foundation for potential pilot programs and collaboration with healthcare providers. Catalyst Crew Technologies intends to integrate modular AI systems such as CardioAI, PulmoAI, and NeuroAI into its broader healthcare infrastructure as development progresses.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "Establishing a local operating presence is an important step in executing our regional strategy. We believe that combining artificial intelligence-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services."
The company plans to prioritize market development in Latin America, where technology-enabled healthcare solutions may help expand access to medical services and improve diagnostic capabilities. By establishing operations in Venezuela, Catalyst Crew Technologies aims to evaluate opportunities and support the implementation of its platforms in a region with growing demand for modernized healthcare delivery.
For more information, visit https://catalystcrewai.com or review the company's SEC filings at www.sec.gov.
